Scholarlink

<p>This pragmatic randomized controlled trial examined the effectiveness of <i>reviga</i>, a self-guided digital intervention based on cognitive behavioral therapy, in reducing work-related stress symptoms. A total of 290 adults experiencing significant stress and burnout were assigned to the intervention group (<i>reviga</i> + treatment as usual [TAU]; n = 147) or the control group (TAU only; n = 143). Intent-to-treat analyses showed that 3 months post-randomization, participants in the intervention group experienced significant positive effects on the primary outcome, perceived stress (Cohen’s <i>d</i> = 0.36), as well as on the secondary outcomes anxiety (<i>d</i> = 0.28), burnout (<i>d</i> = 0.31), occupational and social functioning (<i>d</i> = 0.31) and health-related quality of life (<i>d</i> = 0.35) compared to TAU. No effect was found for absenteeism quantified as the number of sick days. Effect sizes increased at 6 month follow-up. This study demonstrates that <i>reviga</i> represents a promising and scalable tool for workplace mental health support.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A randomized controlled trial of an interactive digital therapeutic for stress and burnout management

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月30日

查看全文
  • Katharina M. Rischer,
  • Linda T. Betz,
  • Antje Riepenhausen,
  • Björn Meyer,
  • Gitta A. Jacob,
  • Helge Frieling,
  • Kamila Jauch-Chara

摘要

This pragmatic randomized controlled trial examined the effectiveness of reviga, a self-guided digital intervention based on cognitive behavioral therapy, in reducing work-related stress symptoms. A total of 290 adults experiencing significant stress and burnout were assigned to the intervention group (reviga + treatment as usual [TAU]; n = 147) or the control group (TAU only; n = 143). Intent-to-treat analyses showed that 3 months post-randomization, participants in the intervention group experienced significant positive effects on the primary outcome, perceived stress (Cohen’s d = 0.36), as well as on the secondary outcomes anxiety (d = 0.28), burnout (d = 0.31), occupational and social functioning (d = 0.31) and health-related quality of life (d = 0.35) compared to TAU. No effect was found for absenteeism quantified as the number of sick days. Effect sizes increased at 6 month follow-up. This study demonstrates that reviga represents a promising and scalable tool for workplace mental health support.